Pharmafile Logo

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

We’re taking a look at the top trends from 2023 and share our predictions for the new year.

Our expert speakers will share their unique industry insights and the “best of the best” virtual collaboration and insight-gathering programs from 2023. They will tie in these trends with tips and best practices for how to optimize your insight-gathering programs, conference engagements, patient-centricity efforts, and HCP- or patient-facing materials.

Register now to learn more about:

  • The most sought-after and innovative digital programs of 2023/24
  • Novel (and more efficient) ways to engage KOLs at conferences
  • Online patient journey mapping for understanding the patient experience and discovering healthcare gaps
  • Asynchronous Delphi reviews for co-creation of consensus papers, guidelines, and other resources
  • Digital Content Councils
  • Benefits of leveraging an all-in-one, proprietary virtual platform for all of the above programs
  • Plus much more!

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Mastering Asynchronous Meetings: Open-Ended Questions – Impetus Digital Tip 1

Unlock the potential of asynchronous virtual meetings with the first tip from our "Top 10 Tips for Optimizing Asynchronous Virtual Meetings".

In-person, hybrid, or digital? State of Pharma meetings and events in 2024

We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

Navigating Regulatory Challenges – Top 10 Most Important Advisor Questions

This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends...

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...